Fig. 2 | Scientific Reports

Fig. 2

From: Clinical characteristics of Torquetenovirus infected immunocompromised patients explored by metagenomic next-generation sequencing

Fig. 2The alternative text for this image may have been generated using AI.

Abundances of TTV in different samples. in immunocompromised and immunocompetent patients. (A) Log10(RPM) of TTV in BALF samples of immunocompromised (red) and immunocompetent patients (green). (B) Log10(RPM) of TTV in blood samples of immunocompromised (blue) and immunocompetent patients (yellow). RPM: The reads per million mapped.

Back to article page